| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CURIS INC | CFO | Employee stock option (right to buy) | 39K | $453K | $11.62 | May 21, 2024 | Direct |
| GENOCEA BIOSCIENCES, INC. | CHIEF FINANCIAL OFFICER | Common Stock | 75.4K | $94.2K | $1.25 | Jun 2, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CRIS | CURIS INC | May 21, 2024 | 1 | $453K | 4 | May 23, 2024 | CFO |
| CRIS | CURIS INC | Jan 20, 2023 | 1 | $0 | 4 | Jan 24, 2023 | CFO |
| CRIS | CURIS INC | Aug 5, 2022 | 0 | $0 | 3 | Aug 10, 2022 | CFO |
| GNCA | GENOCEA BIOSCIENCES, INC. | Jun 2, 2022 | 1 | -$81 | 4 | Jun 3, 2022 | CHIEF FINANCIAL OFFICER |
| GNCA | GENOCEA BIOSCIENCES, INC. | May 26, 2022 | 1 | -$1.87K | 4 | May 26, 2022 | CHIEF FINANCIAL OFFICER |
| GNCA | GENOCEA BIOSCIENCES, INC. | Apr 4, 2022 | 1 | -$1.2K | 4 | Apr 5, 2022 | CHIEF FINANCIAL OFFICER |
| GNCA | GENOCEA BIOSCIENCES, INC. | Mar 15, 2022 | 3 | -$3.16K | 4 | Mar 17, 2022 | CHIEF FINANCIAL OFFICER |
| GNCA | GENOCEA BIOSCIENCES, INC. | Dec 31, 2021 | 2 | -$3.65K | 5 | Mar 16, 2022 | CHIEF FINANCIAL OFFICER |